Literature DB >> 26349628

Synthesis and structure-activity relationships of novel 9-oxime acylides with improved bactericidal activity.

Xu Han1, Wei Lv2, Si-Yang Guo1, Mark Cushman2, Jian-Hua Liang3.   

Abstract

9-Oxime acylides have different SAR and binding modes from 9-oxime ketolides. An aminopyridyl or carbamoylpyridyl group anchored at the end of the 9-oxime 2-propargyl group is beneficial for antimicrobial activity. Both the 2-pyridyl and 3-pyridyl groups derived from 3-OH have stacking interactions with the base pair G2505/C2610 (Escherichia coli numbering) of the bacterial rRNA. Compounds 3 presented characteristic features that belong to bactericidal agents when used against constitutive-erm resistant Staphylococcus aureus, susceptible and mef-encoded Streptococcus pneumoniae, inducible-erm resistant Streptococcus pyogenes, and Moraxella catarrhalis. A docking model indicated that the carbamoylpyridyl group of 3h may hydrogen bond to G2061 in addition to π-π stacking over the adenine of A2062 that proved to gate the tunnel for the egress of the nascent peptide. This study suggests that the 9-oxime acylides possess a bactericidal mechanism that is different from the traditional near-complete inhibition of protein synthesis. These studies provide a foundation for the rational design of macrolide antibiotics.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acylide; Bactericidal activity; Erythromycin; Ketolide

Mesh:

Substances:

Year:  2015        PMID: 26349628     DOI: 10.1016/j.bmc.2015.08.020

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  1 in total

1.  Novel (Z)/(E)-1,2,4-triazole derivatives containing oxime ether moiety as potential ergosterol biosynthesis inhibitors: design, preparation, antifungal evaluation, and molecular docking.

Authors:  Shengxin Sun; Jinghua Yan; Lang Tai; Jianqi Chai; Haoran Hu; Ling Han; Aimin Lu; Chunlong Yang; Min Chen
Journal:  Mol Divers       Date:  2022-03-15       Impact factor: 2.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.